Tuberculosis patients living with HIV receiving antiretroviral therapy in Venezuela, Bolivarian Republic of

Venezuela, Bolivarian Republic of: Tuberculosis patients living with HIV receiving antiretroviral therapy was 301 patients in 2021. ◆ Volatile

Latest (2021)
301 patients
Change on year
up 46.1%
World rank
60th
of 183 countries
All-time high
572 patients
in 2015
All-time low
81 patients
in 2008
Years of data
18
2004–2021

Tuberculosis patients living with HIV receiving antiretroviral therapy in Venezuela, Bolivarian Republic of, 2004–2021

1002003004005006002004201220212004: 114 patients2005: 152 patients2006: 188 patients2007: 159 patients2008: 81 patients2009: 102 patients2010: 156 patients2011: 166 patients2012: 517 patients2013: 517 patients2014: 398 patients2015: 572 patients2016: 485 patients2017: 300 patients2018: 300 patients2019: 304 patients2020: 206 patients2021: 301 patients

Source: Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Measured in patients.

Analysis

In 2021, tuberculosis patients living with hiv receiving antiretroviral therapy in Venezuela, Bolivarian Republic of stood at 301 patients.

Compared with earlier readings it is up 46.1% on the previous year and up 81.3% over ten years.

Over the whole period, tuberculosis patients living with hiv receiving antiretroviral therapy in Venezuela, Bolivarian Republic of peaked at 572 patients in 2015 and was at its lowest, 81 patients, in 2008.

That places Venezuela, Bolivarian Republic of 60th out of 183 countries with data for 2021, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Tuberculosis patients living with HIV receiving antiretroviral therapy in Venezuela, Bolivarian Republic of, year by year

Annual values for Tuberculosis patients living with HIV receiving antiretroviral therapy in Venezuela, Bolivarian Republic of, 2004 to 2021.
Year patients Change
2004 114 patients
2005 152 patients +33.3%
2006 188 patients +23.7%
2007 159 patients -15.4%
2008 81 patients -49.1%
2009 102 patients +25.9%
2010 156 patients +52.9%
2011 166 patients +6.4%
2012 517 patients +211.4%
2013 517 patients +0.0%
2014 398 patients -23.0%
2015 572 patients +43.7%
2016 485 patients -15.2%
2017 300 patients -38.1%
2018 300 patients +0.0%
2019 304 patients +1.3%
2020 206 patients -32.2%
2021 301 patients +46.1%

Averages by decade

DecadeAverage LowestHighest Years
2000s 132.67 patients 81 patients 188 patients 6
2010s 371.5 patients 156 patients 572 patients 10
2020s 253.5 patients 206 patients 301 patients 2

Countries ranked near Venezuela, Bolivarian Republic of

  1. 57 Togo 328 patients compare
  2. 58 Madagascar 322 patients compare
  3. 59 Portugal 303 patients compare
  4. 61 Panama 298 patients compare
  5. 62 Cambodia 275 patients compare
  6. 63 Bolivia, Plurinational State of 266 patients compare

See the full ranking of 183 places →

More health data for Venezuela, Bolivarian Republic of

All data for Venezuela, Bolivarian Republic of →

Frequently asked questions

What is tuberculosis patients living with hiv receiving antiretroviral therapy in Venezuela, Bolivarian Republic of?
Tuberculosis patients living with hiv receiving antiretroviral therapy in Venezuela, Bolivarian Republic of was 301 patients in 2021, according to Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data.
What is the highest tuberculosis patients living with hiv receiving antiretroviral therapy recorded in Venezuela, Bolivarian Republic of?
The highest recorded value was 572 patients in 2015.
What is the lowest tuberculosis patients living with hiv receiving antiretroviral therapy recorded in Venezuela, Bolivarian Republic of?
The lowest recorded value was 81 patients in 2008.
How does Venezuela, Bolivarian Republic of rank for tuberculosis patients living with hiv receiving antiretroviral therapy?
Venezuela, Bolivarian Republic of ranks 60th out of 183 countries with data for 2021.
Is tuberculosis patients living with hiv receiving antiretroviral therapy rising or falling in Venezuela, Bolivarian Republic of?
Over the last ten years it is up 81.3%. The long-run trend across the full record is volatile.
Where does this Venezuela, Bolivarian Republic of data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as part of Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 18 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Tuberculosis patients living with HIV receiving antiretroviral therapy in Venezuela, Bolivarian Republic of. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Retrieved 05 September 2026, from https://health.statizoid.com/stat/tb-patients-living-with-hiv-receiving-art/venezuela-rb/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/tb-patients-living-with-hiv-receiving-art/venezuela-rb/">Tuberculosis patients living with HIV receiving antiretroviral therapy in Venezuela, Bolivarian Republic of</a> — Statizoid

About this data

Indicator
Tuberculosis patients living with HIV receiving antiretroviral therapy
Unit
patients
Source
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
183 places, 2,780 data points, 2000–2021
Last refreshed

Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.